We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+2.34%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$54.7B
AUM Growth
-$333M
Cap. Flow
-$906M
Cap. Flow %
-1.66%
Top 10 Hldgs %
14.84%
Holding
1,599
New
74
Increased
554
Reduced
585
Closed
78

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$114M
2
ORCL icon
Oracle
ORCL
+$96.1M
3
ALL icon
Allstate
ALL
+$88.6M
4
QCOM icon
Qualcomm
QCOM
+$88.3M
5
MRSH
Marsh
MRSH
+$73.9M

Sector Composition

Rank Sector Weight
1 Healthcare 17.55%
2 Financials 15.04%
3 Technology 12.33%
4 Energy 9.55%
5 Industrials 9.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSU
1101
DELISTED
Kansas City Southern
KSU
$1.14M ﹤0.01%
10,900
-8,100
-43% -$759K
VVC
1102
DELISTED
Vectren Corporation
VVC
$1.14M ﹤0.01%
19,500
-6,100
-24% -$366K
TKR icon
1103
Timken Company
TKR
$9.82B
$1.14M ﹤0.01%
24,600
-49,600
-67% -$2.28M
RDN icon
1104
Radian Group
RDN
$5.14B
$1.14M ﹤0.01%
69,500
-126,100
-64% -$2.16M
EDU icon
1105
New Oriental
EDU
$7.84B
$1.13M ﹤0.01%
16,048
+3,153
+24% +$217K
FLXN
1106
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.13M ﹤0.01%
55,917
+338
+0.6% +$7.04K
HMHC
1107
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$1.13M ﹤0.01%
91,756
+698
+0.8% +$8.53K
SRPT icon
1108
Sarepta Therapeutics
SRPT
$1.66B
$1.11M ﹤0.01%
33,000
CXT icon
1109
Crane NXT
CXT
$3.04B
$1.1M ﹤0.01%
40,018
MNRO icon
1110
Monro
MNRO
$525M
$1.1M ﹤0.01%
26,429
+201
+0.8% +$10K
HVT icon
1111
Haverty Furniture Companies
HVT
$401M
$1.1M ﹤0.01%
43,900
AGR
1112
DELISTED
Avangrid, Inc.
AGR
$1.1M ﹤0.01%
24,900
-1,800
-7% -$79.9K
GKOS icon
1113
Glaukos
GKOS
$9.02B
$1.1M ﹤0.01%
+26,470
New +$1.14M
GNTX icon
1114
Gentex
GNTX
$4.88B
$1.1M ﹤0.01%
+58,008
New +$1.13M
HOME
1115
DELISTED
At Home Group Inc.
HOME
$1.09M ﹤0.01%
47,030
+357
+0.8% +$6.76K
KATE
1116
DELISTED
Kate Spade & Company
KATE
$1.09M ﹤0.01%
59,093
-872
-1% -$16.1K
ALSN icon
1117
Allison Transmission
ALSN
$10.1B
$1.09M ﹤0.01%
+29,000
New +$1.08M
AIA icon
1118
iShares Asia 50 ETF
AIA
$4.52B
$1.09M ﹤0.01%
19,000
AIN icon
1119
Albany International
AIN
$2.14B
$1.08M ﹤0.01%
+20,300
New +$983K
CPF icon
1120
Central Pacific Financial
CPF
$1.01B
$1.08M ﹤0.01%
34,200
OI icon
1121
O-I Glass
OI
$1.39B
$1.08M ﹤0.01%
+45,000
New +$989K
SNI
1122
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$1.07M ﹤0.01%
15,722
+35
+0.2% +$2.46K
TTM
1123
DELISTED
Tata Motors Limited
TTM
$1.07M ﹤0.01%
32,412
+2,712
+9% +$94.8K
RLJ icon
1124
RLJ Lodging Trust
RLJ
$1.87B
$1.07M ﹤0.01%
53,675
-9,150
-15% -$196K
CUBI icon
1125
Customers Bancorp
CUBI
$2.59B
$1.07M ﹤0.01%
37,700

Similar funds

Macquarie Group's Q2 2017 Portfolio in Review

As of Q2 2017, Macquarie Group held 1,599 positions worth $54.7B, down 0.61% from $55B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q2 2017 filing shows 74 new, 554 increased, 585 reduced and 78 closed positions. Its largest new stake was Altaba Inc: 830,118 shares worth $45.2M. The largest sale was Quest Diagnostics, an estimated $114M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q2 2017 buy was Altaba Inc: 830,118 shares worth $45.2M.
  • Macquarie Group added most to Marathon Oil Corporation in Q2 2017, an estimated $399M increase.
  • Macquarie Group's biggest Q2 2017 reduction was Quest Diagnostics, cutting an estimated $114M.
  • Macquarie Group fully exited Syngenta Ag in Q2 2017, selling an estimated $69.7M.
  • Macquarie Group's ten largest holdings make up 15% of its $54.7B portfolio in Q2 2017.
  • Macquarie Group opened 74 new positions and closed 78 in Q2 2017.
  • Macquarie Group's portfolio value fell 0.61% quarter-over-quarter to $54.7B.

Based on Macquarie Group's 13F filing for Q2 2017, filed 14 Aug 2017.